Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-29 06:53 am Sale | 2020-12-31 | 13G | Aethlon Medical, Inc. AEMD | Mitchell P. Kopin | 224 1.500% | -181 (-44.73%) | Filing History |
| 2021-01-29 06:51 am Purchase | 2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Mitchell P. Kopin | 3,291,165 6.600% | 3,254,755 (+8939.10%) | Filing History |
| 2021-01-29 06:49 am Sale | 2020-12-31 | 13G | TD Holdings, Inc. GLG | Mitchell P. Kopin | 2,040 0.600% | -1,652 (-44.75%) | Filing History |
| 2021-01-29 06:46 am Unchanged | 2020-12-31 | 13G | XWELL, Inc. XWEL | Mitchell P. Kopin | 247,561 5.000% | 0 (Unchanged) | Filing History |
| 2021-01-29 06:41 am Sale | 2020-12-31 | 13G | Singularity Future Technology Ltd. SGLY | Mitchell P. Kopin | 22,500 3.600% | -9,507 (-29.70%) | Filing History |
| 2021-01-29 06:39 am Purchase | 2020-12-31 | 13G | Aeterna Zentaris Inc. AEZS | Mitchell P. Kopin | 839 5.400% | 314 (+59.92%) | Filing History |
| 2021-01-29 06:36 am Sale | 2020-12-31 | 13G | Recon Technology, Ltd. RCON | Mitchell P. Kopin | 16,389 3.900% | -12,236 (-42.75%) | Filing History |
| 2021-01-29 06:34 am Unchanged | 2020-12-31 | 13G | BIOLASE, Inc. BIOL | Mitchell P. Kopin | 2,298 5.800% | 0 (Unchanged) | Filing History |
| 2021-01-29 06:33 am Sale | 2020-12-31 | 13G | Ra Medical Systems, Inc. RMED | Mitchell P. Kopin | 3,052 4.970% | -647 (-17.50%) | Filing History |
| 2021-01-29 06:32 am Sale | 2020-12-31 | 13G | Iterum Therapeutics plc ITRM | Mitchell P. Kopin | 171,852 4.990% | -7,802 (-4.34%) | Filing History |
| 2021-01-29 06:31 am Unchanged | 2020-12-31 | 13G | Q/C Technologies, Inc. QCLS | Mitchell P. Kopin | 1,459,458 7.500% | 0 (Unchanged) | Filing History |
| 2021-01-29 06:27 am Purchase | 2020-12-31 | 13G | Globus Maritime Limited GLBS | Mitchell P. Kopin | 334,459 9.990% | 334,459 (New Position) | Filing History |
| 2021-01-29 06:26 am Purchase | 2020-12-31 | 13G | Castor Maritime Inc. CTRM | Mitchell P. Kopin | 145,630 9.990% | 103,630 (+246.74%) | Filing History |
| 2021-01-29 06:24 am Sale | 2020-12-31 | 13G | Seanergy Maritime Holdings Corp. SHIP | Mitchell P. Kopin | 355,053 4.900% | -92,394 (-20.65%) | Filing History |
| 2021-01-29 06:23 am Purchase | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Mitchell P. Kopin | 62,229 6.800% | 50,000 (+408.88%) | Filing History |
| 2021-01-29 06:21 am Sale | 2020-12-31 | 13G | ZOMEDICA CORP COM ZOMDF | Mitchell P. Kopin | 13,694,000 2.400% | -1,793,333 (-11.58%) | Filing History |
| 2021-01-29 06:19 am Purchase | 2020-12-31 | 13G | BioLineRx Ltd. BLRX | Mitchell P. Kopin | 478,322 5.200% | 478,322 (New Position) | Filing History |
| 2021-01-29 06:18 am Purchase | 2020-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 4,124 7.200% | 2,380 (+136.51%) | Filing History |
| 2021-01-29 06:16 am Purchase | 2020-12-31 | 13G | Lifeward Ltd. LFWD | Mitchell P. Kopin | 362,463 9.600% | 362,463 (New Position) | Filing History |
| 2021-01-29 06:14 am Unchanged | 2020-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 2,316 5.700% | 0 (Unchanged) | Filing History |